Original Research Article | OPEN ACCESS

Antiretroviral drug adverse reactions among HIV-positive patients at a tertiary care hospital in North-Eastern Nigeria

Shakirat I Bello1 , John D Ohieku2, Nasiru Y Ikunaiye3, Ibrahim M Kida4

1Department of Clinical Pharmacy and Pharmacy Administration, University of Maiduguri, Maiduguri, Nigeria, and Department of Clinical Pharmacy and Pharmacy Practice, University of Ilorin, Nigeria.; 2Department of Clinical Pharmacy and Pharmacy Administration, University of Maiduguri, Maiduguri, Nigeria.; 3Antiretroviral/Infectious Disease Pharmacy Unit, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria.; 4Infectious Disease Unit, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria..

For correspondence:-  Shakirat Bello   Email:  sibello10@yahoo.com   Tel:  +2348035675609

Published: 20 December 2020

Citation: Bello SI, Ohieku JD, Ikunaiye NY, Kida IM. Antiretroviral drug adverse reactions among HIV-positive patients at a tertiary care hospital in North-Eastern Nigeria. J Sci Pract Pharm 2020; 7(1):391-399 doi: 10.47227/jsppharm.v7i1.6

© 2020 The author(s).
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only. .

Abstract

Purpose: The objective of this study was to evaluate the prevalence of adverse drug reactions (ADRs) among patients on antiretroviral drugs in a tertiary healthcare facility in Maiduguri, North-Eastern Nigeria.

Methods: The study was conducted among HIV-positive participants using validated questionnaires and personal interviews to obtain information on ADRs. Participants’ case notes were used to capture data on socio-demographic characteristics, clinical variables, and treatment profiles. The data collected were analyzed with STATA 10 software using logistic regression and descriptive analyses. 

Results:  The prevalence rate of ADRs was 26.6% among 134 patients. Gastrointestinal system disorders 40(8.0%), central and peripheral nervous system 38(7.5%), and systemic signs and symptoms 37(7.3%) were the most common clinical ADRs observed.  Zidovudine/Lamivudine/Nevirapine combination therapy was mostly implicated for the ADRs. Logistic regression analysis showed that the occurrence of ADRs was associated with marital status, viral load, and Zidovudine/Lamivudine/Nevirapine therapy.

Conclusion: The prevalence of ADRs reported in this study was low. Most of the patients with ADRs had mild effects. Marital status, viral load, and Zidovudine/Lamivudine/Nevirapine contributed to the development of the ADRs. There is a need to closely monitor HIV-infected patients by caregivers to further reduce the prevalence of ADRs and concomitant risks.

 

 

Keywords: Antiretrovirals, dolutegravir, gastrointestinal system, human immunodeficiency virus

Journal Metrics
Impact Factors
» Thompson Reuters (ISI): 0.000
» H-5 index: 7 (2024)
» SCImago Journal Rank (SJR): 0.000


Manuscripts
» Submission to first review: 07-14 days
» Submission to acceptance: 20-30 days
» Acceptance to publication: 20-30 days

Article Tools

Share this article with



Archives

2022; 9: 
1.
2021; 8: 
1.
2020; 7: 
1.
2019; 6: 
1.
2018; 5: 
1, 2.
2017; 4: 
1.
2016; 3: 
1.
2015; 2: 
1.
2023; 10: 
1.
2014; 1: 
1.